Literature DB >> 6245589

Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system.

P M Vanhoutte, M N Levy.   

Abstract

In the heart and in the blood vessel walls, complex adrenergic-cholinergic interactions occur both prejunctionally, at the level of the autonomic nerve terminals, and postjunctionally, at the level of the responding cells themselves. The principal prejunctional interaction appears to be an inhibition of the release of norepinephrine from adrenergic nerve terminals by the acetylcholine liberated from nearby cholinergic nerve endings. This inhibitory effect is mediated by muscarinic receptors located on the postganglionic sympathetic nerve terminals. The inhibitory effect of acetylcholine on cardiac and vascular tissues are therefore achieved in part by a direct influence of the cholinergic neurotransmitter on the cardiac and vascular muscle cells, and in part by an indirect influence on sympathetic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245589     DOI: 10.1152/ajpheart.1980.238.3.H275

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  Whole and particle-free diesel exhausts differentially affect cardiac electrophysiology, blood pressure, and autonomic balance in heart failure-prone rats.

Authors:  Alex P Carll; Mehdi S Hazari; Christina M Perez; Quentin Todd Krantz; Charly J King; Darrell W Winsett; Daniel L Costa; Aimen K Farraj
Journal:  Toxicol Sci       Date:  2012-04-26       Impact factor: 4.849

Review 2.  Cardiac autonomic innervation.

Authors:  Hina K Jamali; Fahad Waqar; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2016-11-14       Impact factor: 5.952

Review 3.  Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.

Authors:  Peng-Sheng Chen; Lan S Chen; Michael C Fishbein; Shien-Fong Lin; Stanley Nattel
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

4.  Decreased adrenoceptor stimulation in heart failure rats reduces NGF expression by cardiac parasympathetic neurons.

Authors:  Wohaib Hasan; Peter G Smith
Journal:  Auton Neurosci       Date:  2013-12-04       Impact factor: 3.145

5.  Presynaptic muscarinic receptor subtypes involved in the inhibition of acetylcholine and noradrenaline release in bovine cerebral arteries.

Authors:  M Ferrer; R Galván; J Marín; G Balfagón
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

Review 6.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

7.  Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

8.  Endotoxin impairs the response of rabbit mesenteric artery to electrical stimulation via a prejunctional mechanism.

Authors:  S Tomikawa; E Okabe
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations.

Authors:  T R Porter; D L Eckberg; J M Fritsch; R F Rea; L A Beightol; J F Schmedtje; P K Mohanty
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

10.  Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats.

Authors:  Ian D Wakefield; Julie E March; Philip A Kemp; Jean-Pierre Valentin; Terence Bennett; Sheila M Gardiner
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.